Sentinel lymph node biopsy omission in early-stage breast cancer: current evidence and clinical practice

Sentinel lymph node biopsy omission in early-stage breast cancer: current evidence and clinical practice

Recent trials (e.g., SOUND, INSEMA) indicate that omitting SLNB in patients with small tumors, negative imaging, and favorable prognoses maintains outcomes, reduces complications, and improves quality of life (3,4). Specifically, the INSEMA trial demonstrated that patients who omitted SLNB experienc...

Full description

Saved in:
Bibliographic Details
Main Authors: Tao Huang, Wenkang Wang, Xianfu Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Subjects:
early-stage breast cancer (EBC)
sentinel lymph node biopsy
SLNB omission
axillary management
de-escalation surgery
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1598730/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items